Prominent psychiatric symptoms in patients with Parkinson's disease and concomitant argyrophilic grain disease

Journal of Neurology

Volumn 260, Issue 12, 2013, Pages 3002-3009

  Grau Rivera, O ^a   Gelpi, E ^b   Rey, M J ^b   Valldeoriola, F ^a   Tolosa, E ^a   Compta, Y ^a   Marti M J ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Argyrophilic grain disease; Depression; Parkinson's disease; Psychiatric; Psychosis

Indexed keywords

ALPHA SYNUCLEIN; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUVOXAMINE; IMIPRAMINE; LEVODOPA; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE;

ABNORMAL BEHAVIOR; ADULT; AGED; AGGRESSION; AGGRESSIVENESS; AGORAPHOBIA; ALZHEIMER DISEASE; ANXIETY; ANXIETY DISORDER; ARGYROPHILIC GRAIN DISEASE; ARTICLE; AUDITORY HALLUCINATION; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DELUSION; DELUSIONAL DISORDER; DEMENTIA; DEPRESSION; DISEASE COURSE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEAR; FEMALE; FOLLOW UP; HUMAN; IMMUNOREACTIVITY; IRRITABILITY; LEWY BODY; MAJOR DEPRESSION; MEDICAL RECORD REVIEW; MEMORY DISORDER; MENTAL DISEASE; MENTAL INSTABILITY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; PANIC; PARANOIA; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESTLESSNESS; SUICIDAL IDEATION; SUICIDE ATTEMPT; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; RETROSPECTIVE STUDIES;

EID: 84890803911     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7101-1     Document Type: Article

References (30)

1. Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105(8-9):801-819
2. Pham CT, de Silva R, Haik S, Verny M, Sachet A, Forette B et al (2011) Tau-positive grains are constant in centenarians' hippocampus. Neurobiol Aging 32(7):1296-1303
3. Tolnay M, Schwietert M, Monsch AU, Staehelin HB, Langui D, Probst A (1997) Argyrophilic grain disease: distribution of grains in patients with and without dementia. Acta Neuropathol 94(4):353-358
4. Braak H, Braak E (1989) Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 15(1):13-26
5. Togo T, Sahara N, Yen SH, Cookson N, Ishizawa T, Hutton M et al (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 61(6):547-556
6. Togo T, Isojima D, Akatsu H, Suzuki K, Uchikado H, Katsuse O et al (2005) Clinical features of argyrophilic grain disease: a retrospective survey of cases with neuropsychiatric symptoms. Am J Geriatr Psychiatry 13(12):1083-1091
7. Ikeda K, Akiyama H, Arai T, Matsushita M, Tsuchiya K, Miyazaki H (2000) Clinical aspects of argyrophilic grain disease. Clin Neuropathol 19(6):278-284
8. Martinez-Lage P, Munoz DG (1997) Prevalence and disease associations of argyrophilic grains of Braak. J Neuropathol Exp Neurol 56(2):157-164
9. Kawashima T, Doh-ura K, Iwaki T (1999) Argyrophilic grains in late-onset Creutzfeldt-Jakob diseased brain. Pathol Int 49(5):369-373
10. Sabbagh MN, Sandhu SS, Farlow MR, Vedders L, Shill HA, Caviness JN et al (2009) Correlation of clinical features with argyrophilic grains at autopsy. Alzheimer Dis Assoc Disord 23(3):229-233
11. Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y et al (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63(9):911-918
12. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197-211
13. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123(1):1-11
14. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Garcia-Sanchez C, Gironell A (2008) Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 23(13):1889-1896
15. Aarsland D, Bronnick K, Alves G, Tysnes OB, Pedersen KF, Ehrt U et al (2009) The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 80(8):928-930
16. Fenelon G, Soulas T, Zenasni F, Cleret de Langavant L (2010) The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord 25(6):763-766
17. Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D et al (2010) A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 67(8):996-1001
18. Lee AH, Weintraub D (2012) Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms. Mov Disord 27(7):858-863
19. Kuzuhara S (2001) Drug-induced psychotic symptoms in Parkinson's disease. Problems, management and dilemma. J Neurol 248 Suppl 3:III28-III31
20. Santangelo G, Trojano L, Vitale C, Ianniciello M, Amboni M, Grossi D et al (2007) A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Mov Disord 22(16):2418-2425
21. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Bargallo N et al (2010) Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 81(6):650-657
22. Tolosa E, Gaig C, Santamaria J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72(7 Suppl):S12-S20
23. Myslobodsky M, Lalonde FM, Hicks L (2001) Are patients with Parkinson's disease suicidal? J Geriatr Psychiatry Neurol 14(3):120-124
24. Gotham AM, Brown RG, Marsden CD (1986) Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49(4):381-389
25. Harding AJ, Broe GA, Halliday GM (2002) Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125(Pt 2):391-403
26. Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30(21):7281-7289
27. Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 134(Pt 5):1493-1505
28. Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26(4):343-350
29. Josephs KA, Whitwell JL, Parisi JE, Knopman DS, Boeve BF, Geda YE et al (2008) Argyrophilic grains: a distinct disease or an additive pathology? Neurobiol Aging 29(4):566-573
30. Buongiorno M, Compta Y, Marti MJ (2011) Amyloid-beta and tau biomarkers in Parkinson's disease-dementia. J Neurol Sci 310(1-2):25-30